(Q40453162)

20 September 2017

1 reference

title

HIV-associated diarrhoea and wasting. (English)

1 reference

20 September 2017

0 references

H L DuPont

1

1 reference

20 September 2017

G D Marshall

series ordinal

2

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

20 September 2017

number of pages

5

1 reference

inferred from page(s)

published in

The Lancet

1 reference

20 September 2017

volume

346

1 reference

20 September 2017

issue

8971

1 reference

20 September 2017

page(s)

352-356

1 reference

Small intestinal injury and parasitic diseases in AIDS

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Cryptosporidium and Isospora belli infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

HEp-2 cell-adherent Escherichia coli in patients with human immunodeficiency virus-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Persistent diarrhea and fecal shedding of retroviral nucleic acids in children infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Intestinal secretory IgA immune response against human immunodeficiency virus among infected patients with acute and chronic diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Immediate hypersensitivity reactions in epithelia from rats infected with Nippostrongylus brasiliensis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Serum IgE and human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

HIV antigen stimulates basophil leukocytes from AIDS patients to release histamine due to type I allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Stress and anaphylactic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Irritable bowel syndrome (IBS)--definition and pathophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Efficient management of diarrhea in the acquired immunodeficiency syndrome (AIDS). A medical decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

Inhibition of anaphylaxis-evoked intestinal fluid secretion by the dual application of an H1 antagonist and cyclooxygenase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992229-6

7 January 2021

10.1016/S0140-6736(95)92229-6

Identifiers

DOI

1 reference

20 September 2017

1 reference